What is Scientific Intake?
Scientific Intake operates at the intersection of medical technology and metabolic health, specializing in non-invasive solutions for obesity management. The company's flagship innovation, the SmartByte device, represents a paradigm shift in appetite regulation. By physically modulating oral cavity capacity, the device facilitates a natural physiological response, enabling users to achieve satiety without the reliance on systemic pharmacological interventions or injectable synthetic hormones. With formal FDA clearance and a foundation of rigorous clinical research, Scientific Intake is uniquely positioned to disrupt the weight loss market. The firm addresses a critical demand for drug-free, sustainable alternatives, offering a scalable model that balances high-margin profitability with substantial public health impact. As the global obesity epidemic continues to drive demand for effective interventions, Scientific Intake remains a key player in the development of mechanical, rather than chemical, weight management tools.
How much funding has Scientific Intake raised?
Scientific Intake has raised a total of $4.4M across 2 funding rounds:
Private Equity
$3.6M
Private Equity
$765K
Private Equity (2013): $3.6M, investors not publicly disclosed
Private Equity (2015): $765K, investors not publicly disclosed
Key Investors in Scientific Intake
Undisclosed Investor
An institutional investment firm specializing in late-stage growth capital and medical device commercialization.
Undisclosed Investor
A private equity group focused on scaling innovative healthcare technologies with proven clinical efficacy.
Undisclosed Investor
A strategic investment partner dedicated to supporting high-growth companies in the medical technology and wellness sectors.
What's next for Scientific Intake?
With the recent influx of capital, Scientific Intake is poised to scale its manufacturing and distribution capabilities to meet growing consumer demand. The company's strategic roadmap focuses on expanding its market footprint and deepening its clinical evidence base to support broader adoption among healthcare providers. By leveraging its non-invasive technology, the firm aims to capture a significant share of the weight management market, providing a viable alternative to the current wave of pharmaceutical weight-loss solutions. Future growth will likely involve strategic partnerships with health systems and wellness platforms, ensuring that the SmartByte device becomes a standard tool in comprehensive metabolic health programs. The focus remains on operational excellence and maintaining the high efficacy standards that have defined the company's early success.
See full Scientific Intake company page
